Senators Investigate Insurers’ Role in Removing Thousands from ACA Coverage
Democratic senators are investigating 10 insurers’ role in the Trump administration’s termination of 760,000 ACA enrollees’ coverage over suspected fraud.
Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push
A bipartisan group of six senators introduced a bill to reform the 340B drug program, locking in hospitals' use of contract pharmacies and adding new transparency and compliance rules. The legislation would also kill HHS' contested rebate pilot within a year and replace it with a national data clearinghouse to catch duplicate discounts.
presented by
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Democratic Senators Urge Withdrawal of Interim Final Rule on Medicaid Work Requirements
Democratic senators are urging CMS to withdraw its Medicaid work requirements rule, arguing it will create administrative burdens and cause eligible beneficiaries to lose coverage.
New Bill Led by Democrats Aims to Cap Medicare Out-of-Pocket Costs
The Medicare Cost Cap Act seeks to create a $5,000 cap on out-of-pocket costs for traditional Medicare beneficiaries.
Bipartisan Bill Seeks to Strengthen Oversight of Medicare Advantage
Lawmakers introduced the Medicare Advantage Improvement Act of 2026 to tighten prior authorization rules, boost transparency and curb practices that delay care.
Health Experts Warn of ‘Devastating’ Impact After Senate Rejects ACA Tax Credit Extension
The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups that the move will sharply raise premiums and reduce affordable coverage.
presented by
The Healthcare Payments Industry Faces a Perception Challenge
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
6 Things to Know About Trump’s New CDC Director Pick
President Donald Trump selected Susan Monarez — the current acting director of the Centers for Disease Control and Prevention — to lead the agency going forward. This nomination replaces one that the White House withdrew on March 13, after it became clear that physician and former Republican congressman Dave Weldon would not receive enough Senate votes to be confirmed.
‘Increasingly Concerned’ Senators Launch Investigation Into Private Equity’s Effect on Healthcare
This week, two bipartisan members of the Senate Budget Committee launched an investigation into private equity and its impact on healthcare. They initiated the probe to get answers about “questionable financial transactions” that could be hurting care quality for patients at hospitals owned by private equity firms.
More Than 60 Groups Ask Senate Leadership To Pass Legislation To Lower Drug Prices
In a letter to Senate leadership, several organizations asked for the passing of legislation that would reform the patent system and improve competition in the prescription drug space.
Senators Introduce Bipartisan Bill To Impose Harsher Penalties On Those Who Assault Healthcare Staff
This week, senators introduced a bipartisan bill that would make it a federal crime to assault hospital workers. Even though nearly 40 states have passed laws to intensify penalties for violent acts committed against healthcare personnel, there is currently no federal law protecting hospital employees from assault or intimidation.
presented by
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
Senate Bill Proposes Slashing ‘Red Tape’ Around Biosimilar Interchangeability
Legislation introduced by Utah Senator Mike Lee would eliminate testing to show a biosimilar can be substituted for a reference biologic product. Lee contends the current testing requirement adds costs and delays market access for these lower-cost biological medicines.
Senate Finance Committee Advances Bill Targeting PBMs
The Senate Finance Committee voted 26-1 to advance the Modernizing and Ensuring PBM Accountability Act. The bill has several provisions, including delinking PBM income from prescription drug prices under Medicare Part D and banning spread pricing in Medicaid.
Senators pick two telehealth policy changes that should stay
During a Monday hearing, the Senate Committee on Health, Education, Labor and Pensions discussed which changes to telehealth coverage made during the Covid-19 pandemic should stay.
Lawmakers introduce dueling Covid-19 privacy bills
Congressional Democrats and Republicans introduced privacy bills that attempt to rein in what companies can do with data collected during the Covid-19 pandemic.
Senators threaten to subpoena Cigna in insulin cost probe
Senators Chuck Grassley and Ron Wyden are demanding that Cigna turn over documents on insulin pricing, as part of a larger probe on rising insulin costs. The lawmakers claim that large pharmacy benefit manager Express Scripts, which Cigna acquired in 2018, is failing to comply with the investigation.